| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |